Target intelligence / Profile preview

DEAH-box helicase 15 (DHX15)

Target
DHX15
Molecular classification
Enzyme, RNA helicase, pre-mRNA splicing factor, RNA-binding protein
01

Overview

DEAH-box helicase 15 (DHX15) is an ATP-dependent RNA helicase and pre-mRNA splicing factor encoded by the DHX15 gene. It is part of the DEAH/RHA-box family of RNA helicases, defined by tandem RecA-like domains and a conserved DEAH (Asp-Glu-Ala-His) signature[6][5][7]. DHX15 catalyzes RNA duplex unwinding by hydrolyzing ATP and remodels ribonucleoprotein complexes, functioning in spliceosome disassembly, ribosome maturation, and regulating RNA-protein interactions critical for proper gene expression[1][2]. DHX15’s enzymatic activity and substrate specificity are tightly regulated via recruitment by adapter proteins, most notably G-patch domain-containing proteins, which stabilize its conformation and boost its ATPase and helicase activities[1][4]. Beyond RNA processing, DHX15 plays a key role in innate immune signaling, acting as a cofactor for pattern-recognition receptors (such as NLRP6 and RIG-I), where it binds viral double-stranded RNA and triggers immune cascades, including inflammasome assembly and interferon production[3]. Abnormal regulation or expression of DHX15 is associated with cancer (e.g., T-cell acute lymphoblastic leukemia via effects on RNA splicing and activation of oncogenic pathways)[6], and it can serve as a host factor exploited by viruses for genomic RNA packaging and replication[4]. Due to its broad and essential cellular roles, DHX15 is considered a potential target for both cancer therapy and antiviral strategies, but its inhibition poses significant safety and selectivity challenges.

Other names
ATP-dependent RNA helicase DHX15DBP1DDX15PRP43PrPp43phPrp43PRPF43DEAH (Asp-Glu-Ala-His) box helicase 15Splicing factor Prp43DEAD/H box-15RNA helicase 2
02

Mechanism of action

ATP-dependent unwinding and remodeling of RNA and RNA-protein complexes, facilitated by interaction with G-patch cofactors[1][2][4]. Recruitment by cofactors (e.g., G-patch proteins, pattern recognition receptors) modulates DHX15 cellular localization and activity[2][3][4].

03

Biological functions

RNA metabolismPre-mRNA splicing (spliceosome disassembly and release of lariat introns)Ribosome biogenesisRegulation of RNA-protein complexesInnate immune response (signal transduction in antiviral immunity)
04

Disease associations

Cancer (e.g., implicated in T-cell acute lymphoblastic leukemia and other tumorigenesis via deregulated RNA splicing)Infection (host factor in retroviral RNA packaging and replication, e.g., Mason-Pfizer monkey virus)Modulation of immune responses (via pattern-recognition receptor pathways)
05

Safety considerations

Ubiquity and multifunctionality in key cellular processes, so inhibition could affect essential RNA metabolism and cell viability[1][2][6].Potential risk of off-target effects if used as a therapeutic target, given involvement in both normal and disease contexts.Specificity—DHX15 interacts with numerous partners, and broad inhibition could disrupt multiple pathways.
06

Interacting drugs

None are currently well-established or clinically approved as DHX15-targeted therapies. However, the protein is suggested as a possible therapeutic target in cancer[6], and its mechanism is considered for antiviral strategies[4].
07

Biomarkers

DHX15 expression changes in T-cell acute lymphoblastic leukemia and other cancers could potentially serve as biomarkers of disease or therapeutic response[6].Specific misspliced RNA isoforms resulting from aberrant DHX15 function may also be candidates.

Beyond the preview

Go deeper on DEAH-box helicase 15 (DHX15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEAH-box helicase 15 (DHX15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call